References
- Hammerman C, Kaplan M. Comparative tolerability of pharmacological treatments for patent ductus arteriosus. Drug Saf 2001;24:537–551.
- Rubino CM, Shaffer CL, Gal P, Ransom JL, Kissling GE. Postnatal pharmacologic prevention of intraventricular hemorrhage: meta-analysis of phenobarbital and indomethacin. Pediatr Nurs 1997;23:196–204.
- Miyako Y, Khalef N, Matsuzaki K, Pinal R. Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect. Int J Pharm 2010;393:48–54.
- Kawakami K, Miyoshi K, Ida Y. Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent. J Pharm Sci 2004;93:1471–1479.
- Jain AK. Solubilization of indomethacin using hydrotropes for aqueous injection. Eur J Pharm Biopharm 2008;68:701–714.
- Okore VC. Solubility and stability of indomethacin in sodium acetate solution. A consideration of hydrotropic mechanism. Boll Chim Farm 1997;136:680–684.
- Lin SY, Kawashima Y. Kinetic studies on the stability of indomethacin in alkaline aqueous solution containing poly(oxyethylene)poly(oxypropylene) surface-active block copolymers. Pharm Acta Helv 1985;60:345–350.
- Jansook P, Kurkov SV, Loftsson T. Cyclodextrins as solubilizers: formation of complex aggregates. J Pharm Sci 2010;99:719–729.
- Salústio PJ, Feio G, Figueirinhas JL, Pinto JF, Cabral Marques HM. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity. Eur J Pharm Biopharm 2009;71:377–386.
- Dimitrova E, Bogdanova S, Mitcheva M, Tanev I, Minkov E. Development of model aqueous ophthalmic solution of indomethacin. Drug Dev Ind Pharm 2000;26:1297–1301.
- Hirano A, Kameda T, Arakawa T, Shiraki K. Arginine-assisted solubilization system for drug substances: solubility experiment and simulation. J Phys Chem B 2010;114:13455–13462.
- Arakawa T, Kita Y, Koyama AH. Solubility enhancement of gluten and organic compounds by arginine. Int J Pharm 2008;355:220–223.
- Kato A, Maki K, Ebina T, Kuwajima K, Soda K, Kuroda Y. Mutational analysis of protein solubility enhancement using short peptide tags. Biopolymers 2007;85:12–18.
- Singhai AK, Jain S, Jain NK. Stability studies on aqueous injection of ketoprofen. Pharmazie 1997;52:226–228.
- Agrawal S, Pancholi SS, Jain NK, Agrawal GP. Hydrotropic solubilization of nimesulide for parenteral administration. Int J Pharm 2004;274:149–155.
- Mura P, Maestrelli F, Cirri M. Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids. Int J Pharm 2003;260:293–302.
- Mura P, Bettinetti GP, Cirri M, Maestrelli F, Sorrenti M, Catenacci L. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system. Eur J Pharm Biopharm 2005;59:99–106.
- Das U, Hariprasad G, Ethayathulla AS, Manral P, Das TK, Pasha S et al. Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key. PLoS ONE 2007;2:e1176.
- Ain-Ai A, Gupta PK. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. Int J Pharm 2008;351:282–288.
- Hirano A, Arakawa T, Shiraki K. Arginine increases the solubility of coumarin: comparison with salting-in and salting-out additives. J Biochem 2008;144:363–369.